Clinical Trial

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Enrolling by Invitation Phase 1/2
View on ClinicalTrials.gov →
Summary
The aim of this study is to measure the frequency of menstrual irregularities among adolescent females with Type 1 diabetes mellitus and to assess the therapeutic effect of glucagon-like peptide-1 receptor agonist on menstrual irregularities in adolescent females with Type 1 diabetes mellitus .
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04 -> 2026-12 2026-06-06
minor Completion pushed: 2026-08 -> 2027-03 2026-06-06
Trial Details
NCT Number NCT07319286
Lead Sponsor Ain Shams University
Conditions Menstrual Irregularities, Type1 Diabetes Mellitus, Glucagon-Like Peptide-1 Receptor Agonists, Female Reproductive Health
Enrollment 50 participants
Start Date 2025-08-04
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-05